ESC Premium Access

SLCO1B1 and ABCB1 genetic variations - possible players in management of dyslipidemia: CoLaus(PsyCoLaus) study

Congress Session

About the speaker

Doctor Valeriya Chekanova

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)
0 follower

187 more presentations in this session

The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure

Speaker: Professor J. McMurray (Glasgow, GB)

Thumbnail

CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation

Speaker: Doctor C. Su (Taichung, TW)

Thumbnail

Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study

Speaker: Doctor T. Rhee (Seoul, KR)

Thumbnail

Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry

Speaker: Professor W. Shimizu (Tokyo, JP)

Thumbnail

The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.

Speaker: Doctor S. Alampoondi Venkataramanan (Worcester, US)

Thumbnail

Access the full session

Cardiovascular Disease in Special Populations ePosters

Speakers: Doctor V. Chekanova, Professor J. McMurray, Doctor C. Su, Doctor T. Rhee, Professor W. Shimizu...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

HFpEF: different mechanistic phenotypes require distinct therapeutic strategies – discussion.

29 August 2021

ESC Premium Access

HFpEF as a cardiorenal syndrome.

29 August 2021

ESC Premium Access

HFpEF as a cardiometabolic syndrome.

29 August 2021

This platform is supported by

logo Novo Nordisk